JP2018504911A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018504911A5 JP2018504911A5 JP2017540270A JP2017540270A JP2018504911A5 JP 2018504911 A5 JP2018504911 A5 JP 2018504911A5 JP 2017540270 A JP2017540270 A JP 2017540270A JP 2017540270 A JP2017540270 A JP 2017540270A JP 2018504911 A5 JP2018504911 A5 JP 2018504911A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- tnf
- amino acid
- acid sequence
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015900260A AU2015900260A0 (en) | 2015-01-29 | Therapeutic and diagnostic agents | |
| AU2015900260 | 2015-01-29 | ||
| PCT/AU2016/050052 WO2016119023A1 (en) | 2015-01-29 | 2016-01-29 | Therapeutic and diagnostic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018504911A JP2018504911A (ja) | 2018-02-22 |
| JP2018504911A5 true JP2018504911A5 (enExample) | 2019-03-14 |
Family
ID=56542055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017540270A Pending JP2018504911A (ja) | 2015-01-29 | 2016-01-29 | 治療及び診断剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20180215805A1 (enExample) |
| EP (1) | EP3250589A4 (enExample) |
| JP (1) | JP2018504911A (enExample) |
| AU (1) | AU2016212707A1 (enExample) |
| CA (1) | CA2975017A1 (enExample) |
| WO (1) | WO2016119023A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3939605A1 (en) | 2016-12-09 | 2022-01-19 | Akston Biosciences Corporation | Insulin-fc fusions and methods of use |
| US10093731B2 (en) | 2017-02-24 | 2018-10-09 | Kindred Biosciences, Inc. | Anti-IL31 antibodies for veterinary use |
| US11267862B2 (en) | 2018-06-29 | 2022-03-08 | Akston Biosciences Corporation | Ultra-long acting insulin-Fc fusion proteins and methods of use |
| HUE062719T2 (hu) | 2018-06-29 | 2023-11-28 | Akston Biosciences Corp | Ultra-hosszú hatású inzulin-FC fúziós fehérjék és az alkalmazási eljárások |
| JP7671275B2 (ja) | 2019-08-29 | 2025-05-01 | エランコ・ユーエス・インコーポレイテッド | 動物用の抗ｉｌ３１抗体 |
| KR102865175B1 (ko) | 2019-12-19 | 2025-09-30 | 악스톤 바이오사이언시스 코퍼레이션 | 초-장기 작용 인슐린-fc 융합 단백질 및 사용 방법 |
| US11186623B2 (en) | 2019-12-24 | 2021-11-30 | Akston Bioscience Corporation | Ultra-long acting insulin-Fc fusion proteins and methods of use |
| LT3972987T (lt) | 2020-04-10 | 2023-09-25 | Akston Biosciences Corporation | Antigenui specifinė imunoterapija, skirta sulietiems covid-19 baltymams ir naudojimo būdai |
| US11192930B2 (en) | 2020-04-10 | 2021-12-07 | Askton Bioscences Corporation | Ultra-long acting insulin-Fc fusion protein and methods of use |
| US11198719B2 (en) | 2020-04-29 | 2021-12-14 | Akston Biosciences Corporation | Ultra-long acting insulin-Fc fusion protein and methods of use |
| CN111696624B (zh) * | 2020-06-08 | 2022-07-12 | 天津大学 | 基于自注意力机制的dna结合蛋白鉴定和功能注释的深度学习方法 |
| US11667689B2 (en) | 2021-07-23 | 2023-06-06 | Akston Biosciences Corporation | Insulin-Fc fusion proteins and methods of use to treat cancer |
| EP4762084A1 (de) * | 2023-08-17 | 2026-06-24 | Gottfried Wilhelm Leibniz Universität Hannover (LUH) | Nukleinsäuresequenz, vektor, screening-verfahren und verfahren zur herstellung von rekombinanten antikörpern |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015509714A (ja) * | 2012-02-22 | 2015-04-02 | エヌヴィーアイピー プロプライエタリー リミテッド | 腫瘍壊死因子レセプター融合タンパク質及び前記タンパク質を使用する方法 |
-
2016
- 2016-01-29 WO PCT/AU2016/050052 patent/WO2016119023A1/en not_active Ceased
- 2016-01-29 JP JP2017540270A patent/JP2018504911A/ja active Pending
- 2016-01-29 AU AU2016212707A patent/AU2016212707A1/en not_active Abandoned
- 2016-01-29 US US15/546,889 patent/US20180215805A1/en not_active Abandoned
- 2016-01-29 CA CA2975017A patent/CA2975017A1/en not_active Abandoned
- 2016-01-29 EP EP16742590.9A patent/EP3250589A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017048194A5 (enExample) | ||
| NZ610075A (en) | Cxcr2 binding polypeptides | |
| JP2023179457A5 (enExample) | ||
| JP2016527891A5 (enExample) | ||
| JP2015525217A5 (enExample) | ||
| RU2021134101A (ru) | Модифицированная j-цепь | |
| SI3191511T1 (en) | Improved TNF binders | |
| MX2018010824A (es) | Proteinas de union inducibles y metodos de uso. | |
| JP2013509879A5 (enExample) | ||
| JP2018531624A5 (enExample) | ||
| JP2017501695A5 (enExample) | ||
| JP2013172734A5 (enExample) | ||
| JP2012532601A5 (enExample) | ||
| MX2017016101A (es) | Polinucleotidos y polipetidos de adenovirus. | |
| JP2011155981A5 (enExample) | ||
| NZ629309A (en) | Tumour necrosis factor receptor fusion proteins and methods of using the same | |
| JP2015524403A5 (enExample) | ||
| WO2015107363A3 (en) | Mycobacterial antigen composition | |
| HRP20200511T1 (hr) | Cjepiva protiv bakterija chlamydia sp. | |
| EP4269562A3 (en) | Antigen binding molecules and methods of use thereof | |
| JP2015119721A5 (enExample) | ||
| CN110799522A (zh) | 用于治疗、改善或预防脑出血的肽及其用途 | |
| EA202190240A1 (ru) | Варианты рекомбинантного белка | |
| WO2019057992A3 (en) | ANTI-ADRENOMEDULIN (ADM) BINDER FOR USE IN TREATING OR PREVENTING THE SYMPTOMS OF A DISEASE | |
| JP2016537981A5 (enExample) |